Replimune Group, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 30, 2018 and accepted by EDGAR at Aug 30, 2018, 09:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $0 | us-gaap:Revenues |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $3.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$5.9m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$10.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | −$2.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months2018-04-01 to 2018-06-30 | −$6.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2018-04-01 to 2018-06-30 | $116.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-06-30 | $12.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $55.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $59.3m | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $4.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $11.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-06-30 | −$38.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-18-054279. Last ingested by Listed: Nov 7, 2026, 12:41 ET. Listed shows no prices and gives no investment advice.